Robert Bruce Merrifield

Overview

Robert Bruce Merrifield (July 15, 1921 – May 14, 2006) was an American biochemist who invented solid-phase peptide synthesis (SPPS) in 1963. The method, which anchors the first amino acid of a peptide to an insoluble polymer support and then adds residues one at a time with repeated washing steps, transformed peptide chemistry from an arduous solution-phase enterprise into a reliable, automatable operation. For this work, Merrifield received the 1984 Nobel Prize in Chemistry.

Before SPPS, synthesizing a peptide even a dozen residues long was a multi-year effort requiring extensive purification after each coupling step. Merrifield's insight was that anchoring the growing chain to a solid support made purification trivial: after each coupling, simple washing removed unreacted reagents and byproducts. Combined with protecting-group chemistry adapted from solution-phase work, this allowed the rapid, stepwise assembly of long peptides.

The first automated peptide synthesizer, built in the Merrifield laboratory with John Stewart, appeared in 1965 and produced bradykinin, ribonuclease A, and many other peptides. The technology quickly became foundational to peptide science, neuroendocrinology, and pharmaceutical chemistry.

Background

Merrifield was born in Fort Worth, Texas, and grew up in California during the Depression. He earned his B.A. from the University of California, Los Angeles, in 1943 and his Ph.D. in 1949. After postdoctoral work, he joined the Rockefeller Institute (now Rockefeller University) in New York, where he spent his entire career.

His work on peptide synthesis grew out of practical frustration with the difficulty of making peptides for biological studies. The original 1963 paper describing solid-phase synthesis was modestly titled "Solid-phase peptide synthesis. I. The synthesis of a tetrapeptide" and appeared in the Journal of the American Chemical Society.

Key Contributions

• Invention of solid-phase peptide synthesis (1963).
• First automated peptide synthesizer (1965).
• Synthesis of ribonuclease A (1969) — the first total synthesis of an enzyme.
• Extensive structure-activity studies of bradykinin, glucagon, and other peptides.
• Training of many leading peptide chemists, who carried SPPS to laboratories worldwide.

Timeline

• 1921: Born in Fort Worth, Texas.
• 1949: Ph.D. from UCLA.
• 1949: Joins the Rockefeller Institute.
• 1963: Publishes the first SPPS paper.
• 1965: Automates peptide synthesis.
• 1969: Reports the total synthesis of ribonuclease A.
• 1984: Nobel Prize in Chemistry.
• 1992: Retires from Rockefeller.
• 2006: Dies at age 84.

Modern Relevance

Solid-phase synthesis and its successors (Fmoc-based SPPS, hybrid solution/SPPS strategies, native chemical ligation, flow chemistry, and enzymatic ligation) are the backbone of both academic peptide chemistry and industrial peptide drug manufacturing. Drugs such as semaglutide, liraglutide, octreotide, and many others depend on SPPS for commercial production.

SPPS also made possible systematic exploration of sequence-activity relationships, combinatorial peptide libraries, and rapid synthesis of peptides for research tools, vaccines, and diagnostics. Merrifield's invention stands alongside PCR and DNA sequencing as one of the defining technologies of modern molecular biology. See solid-phase-synthesis-invention for more.

Related Compounds

• Bradykinin
• Ribonuclease A
• Insulin
• Glucagon
• Oxytocin